Abrogation of TGF-β1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition
- 1 November 2009
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 297 (5), L864-L870
- https://doi.org/10.1152/ajplung.00128.2009
Abstract
Idiopathic pulmonary fibrosis (IPF) is a devastating disease with no known effective pharmacological therapy. The fibroblastic foci of IPF contain activated myofibroblasts that are the major synthesizers of type I collagen. Transforming growth factor (TGF)-β1 promotes differentiation of fibroblasts into myofibroblasts in vitro and in vivo. In the current study, we investigated the molecular link between TGF-β1-mediated myofibroblast differentiation and histone deacetylase (HDAC) activity. Treatment of normal human lung fibroblasts (NHLFs) with the pan-HDAC inhibitor trichostatin A (TSA) inhibited TGF-β1-mediated α-smooth muscle actin (α-SMA) and α1type I collagen mRNA induction. TSA also blocked the TGF-β1-driven contractile response in NHLFs. The inhibition of α-SMA expression by TSA was associated with reduced phosphorylation of Akt, and a pharmacological inhibitor of Akt blocked TGF-β1-mediated α-SMA induction in a dose-dependent manner. HDAC4 knockdown was effective in inhibiting TGF-β1-stimulated α-SMA expression as well as the phosphorylation of Akt. Moreover, the inhibitors of protein phosphatase 2A and 1 (PP2A and PP1) rescued the TGF-β1-mediated α-SMA induction from the inhibitory effect of TSA. Together, these data demonstrate that the differentiation of NHLFs to myofibroblasts is HDAC4 dependent and requires phosphorylation of Akt.Keywords
This publication has 33 references indexed in Scilit:
- Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal TransitionPublished by Elsevier BV ,2008
- Histone Deacetylase 5 Acquires Calcium/Calmodulin-Dependent Kinase II Responsiveness by Oligomerization with Histone Deacetylase 4Molecular and Cellular Biology, 2008
- Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid TumorsJournal of Clinical Oncology, 2008
- PP2A Regulates HDAC4 Nuclear ImportMolecular Biology of the Cell, 2008
- Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trialBritish Journal of Cancer, 2007
- Trichostatin A blocks TGF-β-induced collagen gene expression in skin fibroblasts: Involvement of Sp1Biochemical and Biophysical Research Communications, 2007
- Gut-Enriched Krüppel-Like Factor Interaction with Smad3 Inhibits Myofibroblast DifferentiationAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrixProceedings of the National Academy of Sciences of the United States of America, 2006
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- A Model for Binding of Structurally Diverse Natural Product Inhibitors of Protein Phosphatases PP1 and PP2AJournal of Medicinal Chemistry, 1997